Mediar Therapeutics, Inc. — Form D

Mediar Therapeutics, Inc. of BOSTON, MA, a company, filed a Form D exempt-offering notice with the SEC on 2022-12-02. The offering totals $31.8M, of which $31.8M was reported sold. Industry: Other.

Offering

Issuer

Officers, directors & promoters (19)

NameRoleLocation
Nandita ShangariDirectorBoston, MA
Meredith FisherExecutive OfficerHalf Moon Bay, CA
Andreas JurgeitDirectorBoston, MA
Bharat SrinivasaDirectorBoston, MA
Allan MarchingtonDirectorBoston, MA
Rahul BallalDirectorBoston, MA
Rahul BallalExecutive OfficerBoston, MA
Cassidy BlundellDirectorBoston, MA
Maina BhamanDirectorBoston, MA
Adam CottonDirectorBoston, MA
Simon SturgeDirectorBoston, MA
Marie-Claire PeakmanDirectorBoston, MA
Meredith FisherDirectorHalf Moon Bay, CA
Michael BaranDirectorNew York, NY
Anja KonigDirectorBoston, MA
Peter ParkerDirectorBoston, MA
David de GraafDirectorNewton, MA
Brian HubbardDirectorSan Diego, CA
Stacey BrennerExecutive OfficerCambridge, MA

Other filings by this issuer (4)

FiledFormOfferingSold
2025-12-23D$75.7M$37.8M
2024-10-22D/A$85.0M$85.0M
2023-11-09D/A$85.0M$60.6M
2019-02-06D$10.0M$5.0M

More